Evidence map›Paper›PMID 40341262›Full record

ArticlePloS one2025

A conceptual and computational framework for modeling the complex, adaptive dynamics of epidemics: The case of the SARS-CoV-2 pandemic in Mexico.

Christopher R Stephens, Juan Pablo Gutiérrez

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Christopher R StephensC3-Centro de Ciencias de la Complejidad, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Juan Pablo GutiérrezCenter for Policy, Population and Health Research, School of Medicine, Universidad Nacional Autónoma de México, Mexico City, Mexico.ORCID https://orcid.org/0000-0002-0557-5562

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the quest to ensure adequate preparedness for health emergencies caused by infectious disease pandemics, there is a need for tools that can address the myriad relevant questions related to the spread and trajectory of pandemics. A hybrid intelligence model that combines human and artificial intelligence may provide a viable solution, as it can process data from models that comprehensively integrate contextual and direct factors, effectively mimicking the social processes surrounding transmission while incorporating human interpretation to enhance our understanding of pandemics. Using data from the COVID-19 pandemic, we demonstrate the implementation of this approach with the publically available EpI-PUMA (Epidemiological Intelligence Platform for the Universidad Nacional Autónoma de México ("PUMA")) project and platforms, where a user may create their own hybrid intelligence Bayesian classifier models for a range of epidemiological indicators of interest. EPI-Puma integrates data from various public sources (including the national registry of SARS-CoV-2 cases, census data, poverty indicators, climate data and data related to atmospheric contaminants), enabling the deployment of models that predict a range of relevant outcomes. The main criteria for the data included was its coverage (at least at the municipality level) and availability (public data). EPI-Puma was able to identify both the differential predictive value of the different sets of factors related to the epidemic path and well as anticipate with a high probability the path of the pandemic (typical areas under the ROC curve for the associated classifiers being 0.8-0.9).

Indexed as

COVID-19PandemicsArtificial IntelligenceBayes TheoremHumansMexicoSARS-CoV-2

Identifiers

PMID40341262
PMCPMC12061415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.